Boardroom Alpha
Meeting calendar
MSCI · Annual meeting · Tuesday, April 21, 2026

Msci Inc

11 nominees · 3 ballot items.

Election of directors; Advisory (non-binding) vote to approve executive compensation (Say-on-Pay); and ratification of PwC as independent auditor.

Market cap
$45.8B
1Y TSR
+6.4%
Board grade
C+
Record date
Feb 27, 2026
Filing
DEF 14A
Meeting concluded · Apr 21, 2026

Follow how the vote landed and what changed on Msci Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.

Proposals

On the ballot3

  1. 1

    Election of Directors

    ManagementBoard: FOR

    Election of 11 director nominees to hold office until the next annual meeting.

  2. 2

    Advisory Vote to Approve Executive Compensation (Say-on-Pay

    ManagementBoard: FOR

    Non-binding, advisory vote to approve the compensation of MSCI’s Named Executive Officers as disclosed in the Proxy Statement.

    More detail

    This advisory (non-binding) proposal asks shareholders to approve the compensation of MSCI’s named executive officers as disclosed in the proxy materials. Management seeks this annual endorsement to validate its pay program design and to demonstrate alignment between executive pay and shareholder interests; the Board points to its pay-for-performance structure (AIP and LTIP), rigorous performance metrics, stock ownership and retention requirements, clawback policies, and recent program enhancements (e.g., RNN modifier for RSUs and formulaic AIP) as evidence of alignment. Company context includes a strong 2025 financial performance, continued emphasis on recurring revenue, and a special premium-priced stock option (PPO) grant to the CEO in early 2025 intended to reinforce long-term alignment and retention. The Board and Compensation Committee engaged extensively with shareholders in 2025 and note historical high Say-on-Pay support; they emphasize that the vote is advisory but that they will consider significant shareholder opposition and may respond with program changes. Critics could point to the CEO’s $15 million PPO award as an extraordinary grant, and shareholders weighing support will consider the exercise-price hurdles, five-year cliff vesting and retention requirements that limit near-term pay realization. The committee argues the PPOs are highly rigorous (large premium exercise prices and long vesting), and that recent LTIP/ AIP design changes strengthen pay-for-performance alignment. Given MSCI’s business mix (subscription/ recurring revenue, growing AI and private markets offerings), management frames the compensation program changes as targeted to incentivize strategic execution, recurring sales growth and long-term shareholder value. The Board recommends FOR, citing peer benchmarking, independent consultant advice, and investor engagement indicating general comfort with the program’s design and the rigorous features of the CEO special award.

  3. 3

    Ratification of the Appointment of MSCI’s Independent Auditor

    ManagementBoard: FOR

    Ratify the Audit and Risk Committee’s appointment of PricewaterhouseCoopers LLP as MSCI’s independent registered public accounting firm for 2026.

Director elections

Nominees on the ballot11

Independent
Tenure on this board
4.1 yrs
Also a director at
Iron Mountain Inc (IRM)
Independent
Tenure on this board
9.4 yrs
Also a director at
Allstate Corp (ALL)
Independent
Tenure on this board
21.5 yrs
Also a director at
Csx Corp (CSX)
Independent
Tenure on this board
1.9 yrs
Also a director at
Sana Biotechnology Inc (SANA)Metlife Inc (MET)Honeywell Aerospace Inc (HONA)
Independent
Tenure on this board
8.7 yrs
Also a director at
First Industrial Realty Trust Inc (FR)
Independent
Tenure on this board
6.4 yrs
Also a director at
1STDIBSCOM Inc (DIBS)
Independent
Tenure on this board
1.6 yrs
Also a director at
Uipath Inc (PATH)Netapp Inc (NTAP)
Ownership

Top institutional holders10

Latest 13F quarter
1VANGUARD CAPITAL MANAGEMENT LLC6.4%4,653,076$2.5B
2VANGUARD PORTFOLIO MANAGEMENT LLC5.5%4,024,536$2.2B
3STATE STREET CORP4.3%3,114,932$1.7B
4BAMCO INC /NY/3.7%2,699,389$1.5B
5BlackRock, Inc.3.6%2,600,504$1.4B
6GEODE CAPITAL MANAGEMENT, LLC2.4%1,767,712$951M
7T. Rowe Price Investment Management, Inc.2.1%1,507,193$812M
8BlackRock, Inc.2.0%1,481,912$799M
9EDGEWOOD MANAGEMENT LLC1.9%1,401,992$756M
10PRINCIPAL FINANCIAL GROUP INC1.7%1,270,657$685M
Filings

Recent key filings

Periodic reports
Definitive proxies
Reference

Frequently asked questions

When is the Msci Inc 2026 annual meeting?
Msci Inc (MSCI) holds its 2026 annual shareholder meeting on Tuesday, April 21, 2026.
What is the record date for the Msci Inc 2026 meeting?
The record date for the Msci Inc 2026 meeting is Friday, February 27, 2026. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Msci Inc's 2026 meeting?
The board is presenting 11 director nominees at the Msci Inc 2026 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the Msci Inc 2026 meeting?
Shareholders will vote on 3 proposals at the Msci Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer